The Long-Term Effects of Switching from Active Intravenous Bisphosphonate Treatment to Low-Dose Maintenance Therapy in Children with Osteogenesis Imperfecta

Publisher： Karger

E-ISSN： 1663-2826|83|3|183-189

ISSN： 1663-2818

Source： Hormone Research in Paediatrics, Vol.83, Iss.3, 2015-02, pp. : 183-189

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fracture during Intravenous Bisphosphonate Treatment in a Child with Osteogenesis Imperfecta: An Argument for a More Frequent, Low-Dose Treatment Regimen

By  

Hormone Research in Paediatrics, Vol. 81, Iss. 3, 2013-12 ,pp. : 204-210

Karger

Access to resources Recommend Favorite

Efficacy and Safety of Bisphosphonate Therapy in Children with Osteogenesis Imperfecta: A Systematic Review

By  

Hormone Research in Paediatrics, Vol. 84, Iss. 1, 2015-05 ,pp. : 26-42

Karger

Access to resources Recommend Favorite

Low-Dose Flutamide (125 mg/Day) as Maintenance Therapy in the Treatment of Hirsutism

By  

Hormone Research in Paediatrics, Vol. 56, Iss. 1-2, 2002-01 ,pp. : 25-31

Karger

Access to resources Recommend Favorite

Intravenous Pamidronate Treatment in Children with Moderate-to-Severe Osteogenesis Imperfecta Started under Three Years of Age

By  

Hormone Research in Paediatrics, Vol. 79, Iss. 6, 2013-05 ,pp. : 333-340

Karger

Access to resources Recommend Favorite

Zoledronic Acid Treatment in Children with Osteogenesis Imperfecta

By  

Hormone Research in Paediatrics, Vol. 75, Iss. 5, 2011-02 ,pp. : 346-353

Karger

Access to resources Recommend Favorite